Posted May 12, 2020
Serendipity is the word Alan Joslyn uses to describe the meeting and eventual acquisition of a Gainesville-based biotech firm.
“It’s not every day all of a sudden a private company falls in your lap that’s working in COVID-19,” Joslyn, CEO of Oragenics, said. “We thought, ‘Wow, is this for real?'”
The pair met through their lawyer, based in Tampa, and in just two weeks a deal was made: Oragenics would acquire Noachis Terra Inc. and with it, a National Institute of Health license for its work on a coronavirus vaccine.
“They were a private company looking for, essentially, access to capital,” Joslyn said. “We had cash and also a public listing on NYSE. The combination to finance the license [they received for their work] and our desire to expand our portfolio, it was a good match.”
The company was acquired from Joseph Hernandez, the founder and sole shareholder of Noachis Terra for $1.9 million in cash and 9.2 million shares of Oragenics’ stock. Noachis Terra had already acquired a National Institutes of Health license, which works as a patent of sorts and gives the nonexclusive right to make and use technology, which will be evaluated for its commercial potential.
Search the Southeast news by topic, city or state.
Get the TAGTV SE reveal of upcoming Webvisions, event premiers and more. Sign up now!